SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-21-039623
Filing Date
2021-06-10
Accepted
2021-06-10 18:36:44
Documents
2
Period of Report
2020-07-23

Document Format Files

Seq Description Document Type Size
1 FORM 3/A SUBMISSION doc3a.html 3/A  
1 FORM 3/A SUBMISSION doc3a.xml 3/A 1700
2 POA DOCUMENT poa.txt EX-24.3A_991945 3016
  Complete submission text file 0001209191-21-039623.txt   6284
Mailing Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH 3RD FLOOR NEW YORK NY 10010 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ROUTE 141 AND HENRY CLAY ROAD WILMINGTON DE 19880
Business Address
Flannelly Barry P (Reporting) CIK: 0001615842 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-36694 | Film No.: 211009374